NCT04858321

Brief Summary

Type 2 diabetes mellitus (T2DM) is a metabolic condition characterized by chronic hyperglycemia and progressive insulin resistance, which progressively lead to macro- and microvascular damage and subsequent impairments in blood pressure (BP) control. Therapeutic approaches to manage T2DM focus on improving glycaemic control and BP and include pharmaceutical treatments (e.g. Metformin and insulin), physical activity and exercise, and calorie restriction. However, pharmaceutical interventions can be expensive and are associated with low adherence. Although exercise and diet programs have been shown to be effective, like pharmaceutical interventions, they often have poor adherence in people with T2DM. With the number of people with T2DM (464 million) continuing to rise and expected to reach 700 million by 2045, the costs associated with the clinical management of this condition are likely to become unsustainable. There is, therefore, a need to explore the potential of alternative interventions. In particular, interventions which may be cheaper than clinical management and have better adherence than exercise, and hypoglycemic agents, to improve glycemic control and deleterious cardiovascular manifestations of this condition. Passive heating may be one such intervention with therapeutic potential.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 26, 2021

Completed
28 days until next milestone

Study Start

First participant enrolled

May 24, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2022

Completed
2 years until next milestone

Results Posted

Study results publicly available

January 3, 2025

Completed
Last Updated

January 3, 2025

Status Verified

November 1, 2024

Enrollment Period

1.6 years

First QC Date

April 14, 2021

Results QC Date

April 7, 2024

Last Update Submit

November 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Insulin Sensitivity

    Does chronic passive heating improve insulin sensitivity? Calculated using the QUICKI for fasting and Gutt for post-prandial, with glucose and insulin concentrations. A higher value means they have better insulin sensitivity.

    Change from pre (day 1) - post 8-12 days of 1 hour of passive heating

Secondary Outcomes (16)

  • Plasma Glucose Concentration

    pre - post following 8-12 days of 1 hour of passive heating

  • Plasma eHSP70 Concentration

    pre - post following 8-12 days of 1 hour of passive heating

  • Plasma IL-6 Concentration

    pre - post following 8-12 days of 1 hour of passive heating

  • Plasma IL-10 Concentration

    pre - post following 8-12 days of 1 hour of passive heating

  • Resting Metabolic Rate

    pre - post following 8-12 days of 1 hour of passive heating

  • +11 more secondary outcomes

Study Arms (1)

Passive heating

EXPERIMENTAL

8-12 x1 h water immersion (to the clavicle, @40 °C, rectal temperature \~38.5 °C and \<39 °C) sessions over a period of 14 days.

Procedure: Passive heating

Interventions

8-12 x1 h water immersion (to the clavicle, @40 °C, rectal temperature \~38.5 °C and \<39 °C) sessions over a period of 14 days.

Passive heating

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female (post-menopausal) aged 35 years or above.
  • Diagnosed with T2DM as defined by the WHO (≥48 mmol/mol).
  • Participant is willing and able to give informed consent for participation in the study.
  • Participant is able to understand and fully cooperate with the study protocol.

You may not qualify if:

  • Severe peripheral neuropathy (to the point to which they cannot sense temperature)
  • Uncontrolled hypertension (≥180 systolic / 100 diastolic mmHg)
  • Taking any medication which may interfere with data interpretation or safety
  • Who have had a myocardial infarction or cerebro-vascular event
  • Any cardiac abnormalities which restrict hard exercise
  • Current smokers or who have stopped within 3 months
  • Participant is unable to understand and/or fully cooperate with the study protocol
  • Any other serious medical condition which would interfere with data interpretation or safety will be excluded from participation.
  • Skin ulcerations
  • Eczema
  • Pre-existing postural hypertension
  • Existing cardiac diseases (identified during screening)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Sport and Exercise Science

Portsmouth, Hampshire, PO1 2ER, United Kingdom

Location

Results Point of Contact

Title
Dr Anthony Shepherd
Organization
University of Portsmouth

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: We plan to run a within-subject, pre-, post-intervention study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Senior Lecturer in Physical Activity, Exercise and Health

Study Record Dates

First Submitted

April 14, 2021

First Posted

April 26, 2021

Study Start

May 24, 2021

Primary Completion

December 19, 2022

Study Completion

December 19, 2022

Last Updated

January 3, 2025

Results First Posted

January 3, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

There is no plan to release IPD, until all avenues of further funding have been exhausted.

Locations